{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T10:04:35Z","timestamp":1787479475513,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD), involving both Crohn\u2019s disease (CD) and ulcerative colitis (UC), represents a chronic, immune-mediated inflammatory disease due to an uncontrolled, ongoing inflammatory response to intestinal bacteria in those with genetic susceptibility. MicroRNA (miRNA) extrusion from relevant remote organs or tissues is reflected in the expression of miRNAs in serum and plasma. Both UC and CD patients had higher blood levels of expressed miR-199a. Long noncoding RNA (lncRNA) ANRIL is a proinflammatory gene that mediates nuclear factor \u03baB to play a role in inflammatory diseases, such as IBD. The aim of the current study is to investigate the potential role of both miR-199a and ANRIL in diagnosing IBD in adult patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixty-seven IBD patients diagnosed clinically, radiologically, endoscopically, and histologically were included in this prospective cohort study. Participants were classified into 3 groups: the UC group (n = 35), the CD group (n = 32), and the control group (n = 30). Demographics, history taking, laboratory characteristics, and treatments were recorded. Tumor necrosis factor \u03b1, miR-199a, and ANRIL were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The findings suggested that miR-199a and ANRIL might be associated with the occurrence or progression of IBD because both genes were substantially expressed in the peripheral blood of patients with this condition. Receiver-operating characteristic curve analysis indicated that the detection of miR-199a and ANRIL had a predictive sensitivity of 62.9% and 88.6% and a specificity of 70.7% and 96.7% for the occurrence of UC cases, respectively, and a predictive sensitivity of 72.4% and 46.9% and a specificity of 96.7% and 34.7% for the occurrence of CD cases, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both miR-199a and ANRIL are abundant in the sera of IBD adult Egyptian patients (UC and CD). Both can represent a noninvasive marker for early disease diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izad210","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T09:25:44Z","timestamp":1693214744000},"page":"1500-1509","source":"Crossref","is-referenced-by-count":7,"title":["Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"30","author":[{"given":"Randa","family":"Erfan","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat G","family":"Shaker","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-1166","authenticated-orcid":false,"given":"Mahmoud A F","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A M","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Faculty of Medicine, Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S","family":"Gomaa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Faculty of Medicine, Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer K","family":"Abu-El-Azayem","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman M","family":"Zaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Faculty of Medicine, Damietta University , Damietta , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza M","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Samy","sequence":"additional","affiliation":[{"name":"Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"issue":"10080","key":"2024090305515205500_CIT0001","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"The Lancet."},{"issue":"7","key":"2024090305515205500_CIT0002","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ibd.20380","article-title":"Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study","volume":"14","author":"Spehlmann","year":"2008","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2024090305515205500_CIT0003","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity."},{"issue":"1","key":"2024090305515205500_CIT0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev."},{"issue":"1","key":"2024090305515205500_CIT0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"2024090305515205500_CIT0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40246-015-0041-3","article-title":"Epigenetic inheritance and the missing heritability","volume":"9","author":"Trerotola","year":"2015","journal-title":"Hum Genomics"},{"issue":"6","key":"2024090305515205500_CIT0007","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"issue":"30","key":"2024090305515205500_CIT0008","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2024090305515205500_CIT0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1756283X14547360","article-title":"The emerging role of miRNAs in inflammatory bowel disease: a review","volume":"8","author":"Chapman","year":"2015","journal-title":"Therap Adv Gastroenterol."},{"issue":"6","key":"2024090305515205500_CIT0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5483\/BMBRep.2018.51.6.025","article-title":"Long noncoding RNA: multiple players in gene expression","volume":"51","author":"Chen","year":"2018","journal-title":"BMB Rep."},{"issue":"13","key":"2024090305515205500_CIT0011","first-page":"7345","article-title":"Effects of IFNG-AS1 and ANRIL on intestinal epithelial cells and their relationship with colitis","volume":"24","author":"Huang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"7","key":"2024090305515205500_CIT0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biopha.2017.09.107","article-title":"Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer","volume":"96","author":"Xu","year":"2017","journal-title":"Pharmacotherapy."},{"issue":"1","key":"2024090305515205500_CIT0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15476286.2015.1122164","article-title":"Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-\u03baB pathway","volume":"13","author":"Zhou","year":"2016","journal-title":"RNA Biol."},{"issue":"1","key":"2024090305515205500_CIT0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"10","author":"Moher","year":"2012","journal-title":"Int J Surg."},{"issue":"6","key":"2024090305515205500_CIT0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut."},{"issue":"26","key":"2024090305515205500_CIT0016","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med."},{"issue":"3","key":"2024090305515205500_CIT0017","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology."},{"issue":"1-2","key":"2024090305515205500_CIT0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(01)00396-5","article-title":"Comparison of BD Vacutainer SST\u2122 plus tubes with BD SST\u2122 II plus tubes for common analytes","volume":"306","author":"Bush","year":"2001","journal-title":"Clin Chim Acta."},{"issue":"1-2","key":"2024090305515205500_CIT0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-018-3351-7","article-title":"Possible use of miRNAs-146a and-499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis","volume":"449","author":"Ayeldeen","year":"2018","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2024090305515205500_CIT0020","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1038\/s41598-017-16500-4","article-title":"Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients","volume":"7","author":"Shaker","year":"2017","journal-title":"Sci Rep."},{"issue":"4","key":"2024090305515205500_CIT0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"2024090305515205500_CIT0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12031-016-0741-8","article-title":"Expression profile of long non-coding RNAs in serum of patients with multiple sclerosis","volume":"59","author":"Santoro","year":"2016","journal-title":"J Mol Neurosci."},{"key":"2024090305515205500_CIT0023","doi-asserted-by":"crossref","first-page":"5126048","DOI":"10.1155\/2017\/5126048","article-title":"The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer","volume":"2017","author":"Luo","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"3","key":"2024090305515205500_CIT0024","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3748\/wjg.v20.i3.814","article-title":"Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt","volume":"20","author":"Esmat","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"11","key":"2024090305515205500_CIT0025","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1007\/s10620-020-06093-w","article-title":"lncRNA MALAT1 promotes ulcerative colitis by upregulating lncRNA ANRIL","volume":"65","author":"Zhu","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"3","key":"2024090305515205500_CIT0026","doi-asserted-by":"crossref","first-page":"G446","DOI":"10.1152\/ajpgi.00212.2016","article-title":"A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation","volume":"311","author":"Padua","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"1","key":"2024090305515205500_CIT0027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2018.11.100","article-title":"Long noncoding RNA ANRIL contributes to the development of ulcerative colitis by miR-323b-5p\/TLR4\/MyD88\/NF-\u03baB pathway","volume":"508","author":"Qiao","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"2024090305515205500_CIT0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-015-0162-2","article-title":"Transcriptomic landscape of lncRNAs in inflammatory bowel disease","volume":"7","author":"Mirza","year":"2015","journal-title":"Genome Med"},{"issue":"4","key":"2024090305515205500_CIT0029","doi-asserted-by":"crossref","first-page":"101895","DOI":"10.1016\/j.clinre.2022.101895","article-title":"Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease","volume":"46","author":"Xia","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"2024090305515205500_CIT0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000505154","article-title":"The long noncoding RNA ANRIL promotes cell apoptosis in lipopolysaccharide-induced acute kidney injury mediated by the TLR4\/nuclear factor-kappa B pathway","volume":"45","author":"Zhu","year":"2020","journal-title":"Kidney Blood Press Res"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad210\/55144466\/izad210.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/9\/1500\/58843797\/izad210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/9\/1500\/58843797\/izad210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T01:52:13Z","timestamp":1725328333000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/9\/1500\/7512920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad210","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,1,8]]}}}